Dopaminergic Therapy Improves Cognitive Motivation in Parkinson’s Patients, Study Reports

Dopaminergic Therapy Improves Cognitive Motivation in Parkinson’s Patients, Study Reports
Dopaminergic treatment normalizes cognitive motivation in patients with Parkinson’s disease, making them more likely to choose a higher reward option in a computer-based task, a study reports. The study, “Dopamine restores cognitive motivation in Parkinson’s disease,” was published in the journal Brain. Approximately 40 percent of Parkinson’s patients experience a decrease in motivation, including cognitive apathy, which may manifest as ... read more
Source: Parkinson’s News TodayPublished on 2019-01-29By Jose Marques Lopes, PhD